Ali Shafiq is a Cardiology physician. OpenAlex indexes 52 publications with 515 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2799 W Grand Blvd
Detroit, MI 482022608
Telephone
313-743-4012Provider last certified this registry record 24 Aug 2020.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20257 payments
- HEARTFLOW, INC.Program year20251 payment
- ABIOMEDProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.3%Beta blocker21.6%Metoprolol Succinate61%Carvedilol25%Metoprolol Tartrate14%Part D≥135 patientsStatin16.3%Atorvastatin Calcium69%Rosuvastatin Calcium29%Simvastatin3%Part D<11 patients+ 13 more classes in this area
Blood & clotting
13.3%Factor Xa inhibitor6.6%Eliquis77%Xarelto23%Part D≥38 patientsP2Y12 inhibitor5.1%Clopidogrel75%Brilinta25%Part D≥47 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.4%SGLT2 inhibitor1.6%Jardiance100%Part D≥20 patientsPotassium supplement1.6%Potassium Chloride69%Klor-Con M2031%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Squamous Cell Carcinoma of the Tongue with Metastasis to Myocardium: Report of a Case and Literature Review
Case Reports in Cardiology
2019 - SQUAMOUS CELL CARCINOMA OF THE TONGUE WITH METASTASIS TO THE MYOCARDIUM: A RARE OCCURRENCE
Journal of the American College of Cardiology
2019 - Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction
Journal of the American College of Cardiology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”